May 16, 2008
Imugene develops vaccine to fight coccidiosis in poultry
Imugene Ltd said that its Imugene/Abic vaccine induced protection against poultry disease coccidiosis, based on trials conducted by Abic Biological Laboratories and the University of Technology in Sydney.
The vaccine candidate groups that produced the most protection were orally vaccinated at 1 day old and day 14.
The next stages in the development of the vaccine will require trial to determine a minimum dose and an optimum date of administration for protection.
Imugene said that coccidiosis, one of the most common and costly diseases in poultry, causes weight loss and poor feed conversion, with a high death rate.
Coccidiosis preventatives and treatments are the second biggest poultry health product category to in-feed antibiotics.










